Form 4 for EW Edwards Lifesciences
Accepted 2022-02-22 00:00:00 ET · period of report 2022-02-21 · accession 0001225208-22-002983 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-22 | 2022-02-21 | EW | Ullem Scott B. | CFO, CVP | F - Tax | $105.62 | -319 | 36.8K | -0.9% | -$33.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-21 | F | D | 319 | $105.62 | 36,812 | D | — | — |